Electroneum (ETN) CEO Richard Ells presented at #BCISummit on the 12th of June 2018, on the subject of ‘Which Cryptocurrencies Will Emerge as the FinTech Leaders of the Future?’ In..
Jubilee Metals Group PLC (LON:JLP) Chief Executive Officer Leon Coetzer caught up with DirectorsTalk for an exclusive interview to discuss their recent project status update. Q1: It looks like..
Maestrano Group PLC (LON:MNO), the open cloud business integration platform with cross-app data synchronization, has today announced the appointment of Chris Constantine as Vice President Engineering. This is the..
Veltyco Group PLC (LON:VLTY) Non-Executive Chairman Gilles Ohana caught up with DirectorsTalk for an exclusive interview to discuss their final results for the year ended 31st December 2017. Q1:..
Widecells Group Plc (LON:WDC) CEO João Andrade & CFO David Bridgland talk to DirectorsTalk about the lifting of a trading suspension. João explains why the shares were suspended, if anything..
Surface Transforms Plc (LON:SCE) provides the following pre-close trading update for the year ended 31 May 2018 together with updates on progress with customers and operations. Financial highlights · Revenue..
Microsaic Systems plc (LON:MSYS), the developer of point of need mass spectrometry instruments, is pleased to announce that it has signed an agreement with Omicron Research Ltd. to distribute Microsaic’s..
Ilika Plc (LON:IKA), a pioneer in solid-state battery technology and materials innovation, announced today further details regarding the grant funding through the Faraday Battery Challenge announced yesterday (see below). The..
Evgen Pharma plc (LON:EVG), the clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces its final results for the year ended 31 March 2018...
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, announced today that Ewan Phillips has resigned as Chief Executive and as a Director of the Company with..
4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, has today announced that the Company has received clearance from the Medicines and Healthcare Products Regulatory Agency..
